Circulating Monoamine Oxidase B and Phenolsulfotransferase Activities in Essential Hypertensive Patients

References

• Murphy D. L., Donnelly C. H. Monoamine oxidase in man: enzyme characteristics in platelets, plasma, and other human tissues. Neuropsychopharmacology of Monoamines and their regulatory enzymes, E. Usdin. Raven Press, New York 1974; 71–85
   Google Scholar
• Kitahama K., Arai R., Maeda T., Jouvet M. Demonstration of monoamine oxidase type B in serotoninergic and type A in noradrenergic neurons in the cat dorsal pontine tegmentum by an improved histochemical technique. Neurosci. Lett. 1986; 71: 19–24
   PubMed Web of Science ®Google Scholar
• Hart R. F., Renskers K. J., Nelson E. B., Roth J. A. Localization and characterization of phenolsulfotransferase in human platelets. Life Sci. 1979; 24: 125–130
   PubMed Web of Science ®Google Scholar
• Rein G., Glover V., Sandler M. Multiple forms of phenolsulfotransferase in human tissues, selective inhibition by dichloronitrophenol. Biochem. Pharmacol. 1982; 31: 1893–1897
   PubMed Web of Science ®Google Scholar
• Anderson R. J., Jackson B. L. Human platelet phenolsulfotransferase: stability of two forms of the enzyme with time and presence of a racial difference. Clin. Chim. Acta 1984; 138: 185–196
   PubMed Web of Science ®Google Scholar
• Weiss H. J., Tschopp T. B., Rogers J., Brand H. Studies of platelet 5–HT in storage pool disease and albinism. J. Clin. Invest. 1974; 54: 421–432
   PubMed Web of Science ®Google Scholar
• Fowler C. J., Tipton K. F. Deamination of 5–hydroxytryptamine by both forms of monoamine oxidase in the rat brain. J. Neurochem. 1982; 38: 733–736
   PubMed Web of Science ®Google Scholar
• Da Prada M., Picotti G. B., Kettler R., Launay J. M. Serotonin, histamine, catecholamine, normetanephrine and octopamine in blood platelets. Platelets: cellular response mechanisms and their biological significance, A. Rotman, F. A. Meyer, G. Gittler, A. Silberberg. John Wiley and Sons Ltd Chichester. 1980; 277–288
   Google Scholar
• Costa J. L., Murphy D. L., Kafka M. S. Demonstration and evaluation of apparent cytoplasmic and vesicular serotonin compartments in human platelets. Biochem. Pharmacol. 1977; 26: 517–521
   PubMed Web of Science ®Google Scholar
• Guicheney P., Baudouin-Legros M., Valier D., Meyer P. Reduced serotonin content and uptake in platelets from patients with essential hypertension: is a ouabain-like factor involved?. Thromb. Res. 1987; 45: 289–298
   PubMed Web of Science ®Google Scholar
• Wurtman R. J., Axelrod J. A sensitive and specific assay for the estimation of monoamine oxidase. Biochem. Pharmacol. 1963; 12: 1439–1441
   PubMed Web of Science ®Google Scholar
• Foldes A., Meek J. L. Rat brain phenolsulfotransferase. Partial purification and some properties. Biophys. Acta 1973; 327: 365–374
   PubMed Web of Science ®Google Scholar
• Soliman H. R., Oset-Gasque M. J., Launay J. M., Sous P., Dreux C. Phenolsulfotransferase activity in human whole blood: radiochemical microassay. Biogenic Amines, (in press)
   Web of Science ®Google Scholar
• Murphy D. L., Costa J. L., Shafer B., Corash L. Monoamine oxidase activity in different density gradient fractions of human platelets. Psychopharmacol. 1978; 59: 193–197
   Web of Science ®Google Scholar
• Weinshilboum R. M., Anderson R. J. Phenolsulfotransferase in human platelets and other tissues: endogenous inhibitors, assay conditions, tissue and substrate correlations. Phenolsulfotransferase in Mental Health Research, M. Sandler, E. Usdin. Mac Millan Press. 1981; 8–28
   Google Scholar
• Murphy D. L., Wright C., Buchsbaum M., Nichols A., Costa J. L., Wyatt R. J. Platelet and plasma amine oxidase activity in 680 normals: sex and age differences and stability over time. Biochem. Med. 1976; 16: 254–265
   Web of Science ®Google Scholar
• Kuchel O., Buu N. T., Hamet P., Larochelle P., Bourque M., Genest J. Catecholamine sulfates and platelet phenolsulfotransferase activity in essential hypertension. Lab. Clin. Med. 1984; 104: 238–244
   PubMed Web of Science ®Google Scholar
• Sandler M., Revely M. A., Glover V. Human platelet monoamine oxidase activity in health and disease: a review. J. Clin. Path. 1981; 34: 292–302
   PubMed Web of Science ®Google Scholar
• Nies A., Robinson D. S., Lamborn K. E., Lampert R. P. Genetic control of platelet and plasma monoamine oxidase activity. Arch. Gen. Psychiatry 1973; 28: 834–842
   PubMed Web of Science ®Google Scholar
• Wyatt R. J., Murphy D. L., Belmaker R., Cohen S., Donnelly C. H., Pollin W. Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia. Science 1973; 179: 916–918
   PubMed Web of Science ®Google Scholar
• Anselmi B., Buffoni F., Curradi C., Del Bianco P. L., Sicureti F. Monoamine oxidase defect in essential arterial hypertension. A single dose pargyline test. Monogr. Neural. Sci. 1976; 3: 115–123
   PubMedGoogle Scholar
• DeMaria F. Placental monoamine oxidase in normal and toxemic patients. Am. J. Obst. Gynec. 1964; 88: 490–494
   PubMed Web of Science ®Google Scholar
• Klinge O., Pentilla O., Tissari O. A. The content of 5–hydroxytryptamine in human uterine and placental tissue, and their 5–hydroxytryptophan decarboxylase and monoamine oxidase activities in normal and toxaemic pregnancies. Acta Obst. Gynec. Scandinav. 1964; 43: 107–114
   PubMed Web of Science ®Google Scholar
• Gentil V., McCurdy R. L., Alevizos B., Lader M. H. Effects of adrenaline injection on human plasma tryptophan and non esterified fatty acids. Psychopharmacol. 1976; 50: 187–192
   PubMed Web of Science ®Google Scholar
• Franco-Morselli R., de Mendonça M., Baudouin-Legros M., Guicheney P., Meyer P. Plasma catecholamines in essential human hypertension and in DOCA-salt hypertension of the rat. Nervous System and Hypertension, P. Meyer, H. Schmitt. Wiley, New York 1979; 287–296, Flammarion/Paris
   Google Scholar
• Demish L., Gebhart P., Kaczmarczyk P., Roser M. Factors that may regulate MAO activity. Monoamine Oxidase and Disease, K. F. Tipton, P. Dostert, M. Strolin Benedetti. Academic Press, London 1984; 253–263
   Google Scholar
• Erne P., Bolli P., Burgisser E., Bühler F. R. Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. New Engl. J. Med. 1984; 310: 1084–1088
   PubMed Web of Science ®Google Scholar
• Valtier D., Guicheney P., Baudouin-Legros M., Meyer P. Platelets in human hypertension: in vitro hyperreactivity to thrombin. J. Hypertension 1986; 4: 551–555
   PubMed Web of Science ®Google Scholar
• Erne P., Resink T. J., Bolli P., Hefti A., Ritz R., Bühler F. R. Free calcium response to adrenaline in platelets of normal and hypertensive (untreated and treated) subjects. J. Hypertension 1984; 2(suppl. 3)159–161
   Google Scholar
• Dimitrov D., Resink T. J., Dimitrov D., Muller F. B., Bühler F. R. Altered platelet phosphatidylinositol metabolism in essential hypertension. J. Hypertens. 1986; 4(suppl. 6)S346–S 348
   Google Scholar
• Demish L. Short-term alteration of MAO activity after translocation of calcium in human blood platelets. Life Sci. 1981; 28: 1995–2002
   PubMed Web of Science ®Google Scholar
• Van Knorring L., Oreland L., Haggendal J. Relationship between platelet MAO activity and concentrations of 5–HIAA and HVA in cerebrospinal fluid in chronic pain patients. J. Neural Transm. 1986; 66: 37–46
   PubMed Web of Science ®Google Scholar
• Guicheney P., Dard B., Valtier D., Baudouin-Legros M. Platelet serotonin in primary hypertension. Neuronal Messengers in Vascular Function, A. Nobin, C. Owman, B. Arneklo-Nobin. Elsevier Science Publishers. 1987; 85–90
   Google Scholar